A detailed history of Crews Bank & Trust transactions in Eli Lilly & CO stock. As of the latest transaction made, Crews Bank & Trust holds 5,984 shares of LLY stock, worth $5.3 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares
5,984
Previous 6,045 1.01%
Holding current value
$5.3 Million
Previous $4.67 Billion 5.9%
% of portfolio
0.84%
Previous 0.79%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 22, 2025

SELL
$725.72 - $929.72 $44,268 - $56,712
-61 Reduced 1.01%
5,984 $4.94 Billion
Q4 2024

Jan 23, 2025

BUY
$727.2 - $932.06 $4.4 Million - $5.63 Million
6,045 New
6,045 $4.67 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $841B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Crews Bank & Trust Portfolio

Follow Crews Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crews Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Crews Bank & Trust with notifications on news.